Menu
AmplifyBio’s comprehensive study management services are designed to provide you with the support and expertise needed to bring your compounds from concept to clinical success. Partner with us to experience the benefits of a well-managed, high-quality preclinical study.
At AmplifyBio, we are committed to providing meticulous study management to ensure the success of your preclinical studies, whether they are GLP or non-GLP. Our structured and collaborative approach ensures clear communication, efficient processes, and high-quality results. All of our Study Directors are experts in conducting GLP and non-GLP studies.
Pre-study Meeting with Key Personnel:
Post-Contract Engagement:
Study Execution:
Our dedicated study management team is here to support you at every stage of your preclinical studies. From the initial engagement to the final report, we prioritize communication, quality, and efficiency to help you achieve your research goals.
Preclinical CRO services play a crucial role in drug development by conducting studies and experiments on potential therapeutics before they advance to clinical trials. AmplifyBio offers a wide-range of preclinical CRO services including:
Comprehensive service programs for the development of Cell and Gene Therapy (CGT), mRNA, and other advanced therapies from concept to commercial. Offering expertise and support in discovery, characterization, preclinical CRO safety testing, and scalable manufacturing available in an integrated, innovation-rich environment that goes beyond the value proposition offered by traditional CDMO and PDMO contract models.
